Viewing Study NCT00683969


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-01-02 @ 10:58 PM
Study NCT ID: NCT00683969
Status: COMPLETED
Last Update Posted: 2008-05-26
First Post: 2008-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: WX17798
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Clinical Trials, Study Director
Old Organization: Hoffmann-La Roche

Collaborators

Collaborators

Name Class View
None INDUSTRY View